Understanding how brain function affects speech in individuals with 16p11.2 deletion syndrome

Phenotyping the neural basis of sensorimotor control of speech in 16p11.2 deletion syndrome

NIH-funded research University of California, San Francisco · NIH-11051001

This study is looking at the speech difficulties that people with 16p11.2 deletion syndrome face, especially since this condition is often linked to autism, and it aims to understand how their brains and body movements affect their ability to speak, comparing their experiences with those of others with autism and those who develop typically.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco NIH-funded
Lab location1 site (San Francisco, United States)
Project IDNIH-11051001 on NIH RePORTER

What this research studies

This research investigates the speech production challenges faced by individuals with 16p11.2 deletion syndrome, a genetic condition often associated with autism and other neurodevelopmental disorders. By examining the neural processes and sensorimotor control involved in speech, the study aims to identify the underlying mechanisms contributing to speech impairments. Participants will be compared with individuals who have idiopathic autism and typically developing peers to gain insights into the specific difficulties experienced by those with the deletion syndrome. The research will involve detailed assessments of speech abilities and brain function to enhance our understanding of these communication challenges.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with 16p11.2 deletion syndrome, particularly those experiencing speech production difficulties.

Not a fit: Patients without the 16p11.2 deletion syndrome or those who do not have speech impairments may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved interventions and support for individuals with speech impairments related to 16p11.2 deletion syndrome.

How similar studies have performed: Previous research has shown promising results in understanding speech impairments in autism, suggesting that this approach could yield valuable insights.

Where this research is happening

San Francisco, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.